受注:045-509-1970 |
技術サポート:[email protected] 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
Synonyms | N/A | Storage (From the date of receipt) |
3 years -20°C powder | |
化学式 | C21H19F2N5O |
|||
分子量 | 395.41 | CAS No. | 1303420-67-8 | |
Solubility (25°C)* | 体外 | DMSO | 79 mg/mL (199.79 mM) | |
Water | Insoluble | |||
Ethanol | Insoluble | |||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
製品説明 | PLX5622 is a highly selective CSF-1R inhibitor (IC50 < 10 nmol/L), showing > 20-fold selectivity over KIT and FLT3. |
---|---|
in vitro | PLX5622 is a highly selective CSF-1R inhibitor (IC50 < 10 nmol/L), showing > 20-fold selectivity over KIT and FLT3. |
in vivo | In vivo PLX5622 demonstrates desirable PK properties in mice, rats, dogs, and monkeys, with a brain penetrance of ~20%. PLX5622 has low systemic clearance, moderate volume of distribution, and favorable oral bioavailability (F > 30%) in all four species. PLX5622 is a useful compound for investigating microglial dynamics. It allows for the sustained and specific elimination of microglia, preceding and during pathology development of Alzheimer’s disease (AD). Long-term PLX5622-mediated microglial depletion is highly robust, sustainable, and specific to the microglial compartment[1]. |
細胞アッセイ | 細胞株 | Cell-free assays |
---|---|---|
濃度 | < 10 nM | |
反応時間 | ||
実験の流れ | ||
動物実験 | 動物モデル | AQP1 mice |
投薬量 | 100 mg/kg | |
投与方法 | o.g. |
CD22 blockade modulates microglia activity to suppress neuroinflammation following intracerebral hemorrhage [ Pharmacol Res, 2023, 196:106912] | PubMed: 37696483 |
Microglial Galectin3 enhances endothelial metabolism and promotes pathological angiogenesis via Notch inhibition by competitively binding to Jag1 [ Cell Death Dis, 2023, 14(6):380] | PubMed: 37369647 |
Microglial Galectin3 enhances endothelial metabolism and promotes pathological angiogenesis via Notch inhibition by competitively binding to Jag1 [ Cell Death Dis, 2023, 14(6):380] | PubMed: 37369647 |
Microglia-Derived Spp1 Promotes Pathological Retinal Neovascularization via Activating Endothelial Kit/Akt/mTOR Signaling [ J Pers Med, 2023, 13(1)146] | PubMed: 36675807 |
A novel histone deacetylase inhibitor-based approach to eliminate microglia and retain astrocyte properties in glial cell culture [ J Neurochem, 2022, 10.1111/jnc.15581] | PubMed: 35092690 |
Distinguished Functions of Microglia in the Two Stages of Oxygen-Induced Retinopathy: A Novel Target in the Treatment of Ischemic Retinopathy [ Life (Basel), 2022, 12(10)1676] | PubMed: 36295111 |
A Pro-inflammatory Stimulus Disrupts Hippocampal Plasticity and Learning via Microglial Activation and 25-Hydroxycholesterol [ J Neurosci, 2021, JN-RM-1502-21] | PubMed: 34725187 |
Down-regulation of Aquaporin-1 mediates a microglial phenotype switch affecting glioma growth [ Exp Cell Res, 2020, 396(2):112323] | PubMed: 33058832 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。